J2KBIO Co., Ltd. (KOSDAQ:420570)
South Korea · Delayed Price · Currency is KRW 9,430.00
-780.00 (-7.64%)
At close: Sep 3, 2026
J2KBIO Market Cap
J2KBIO has a market cap or net worth of 55.2 billion as of September 4, 2026. Its market cap has increased by 3.85% in one year.
Market Cap
55.20B
Enterprise Value
46.34B
Revenue
43.90B
Ranking
n/a
PE Ratio
9.49
Stock Price
9,430.00
ChartMarket Cap Chart
Since March 25, 2024, J2KBIO's market cap has decreased from 144.93B to 55.20B, a decrease of -61.91%. That is a compound annual growth rate of -32.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 55.20B | 9.77% |
| Dec 30, 2025 | 50.29B | -3.28% |
| Dec 30, 2024 | 52.00B | -64.12% |
| Mar 25, 2024 | 144.93B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ADBiotech | 67.78B |
| PanGen Biotech | 67.17B |
| Psomagen | 66.17B |
| Naturalendo Tech | 65.67B |
| NovMetaPharma | 62.80B |
| ABION | 60.91B |
| TegoScience | 60.45B |
| QuadMedicine | 56.26B |